Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 11Colonic Neoplasms 9Carcinoma, Hepatocellular 9Esophageal Neoplasms 6Rectal Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 4Anus Neoplasms 4Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Cholangiocarcinoma 2Bile Duct Neoplasms 2Acquired Immunodeficiency Syndrome 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Papillomavirus Infections 1

Interventions

Cisplatin 116Radiotherapy 84Paclitaxel 77Fluorouracil 62Carboplatin 41Drug Therapy 38pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Neoadjuvant Therapy 24Oxaliplatin 23toripalimab 22sintilimab 19camrelizumab 19Radiation 19Esophagectomy 18Capecitabine 17130-nm albumin-bound paclitaxel 17Surgical Procedures, Operative 16Nivolumab 16Leucovorin 15Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10Immune Checkpoint Inhibitors 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Observation × Gastrointestinal × Clear all
NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Sichuan University

Phase NA Not yet recruiting
98 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡